Could less surgery work just as well for advanced melanoma?

NCT ID NCT07049276

Recruiting now Disease control Sponsor: Melanoma Institute Australia Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a less extensive lymph node surgery is as effective as the standard, more extensive surgery for people with stage III melanoma who have already received immunotherapy. After 6 weeks of immunotherapy drugs, participants will be randomly assigned to have either just the main affected lymph node removed or the standard removal of all lymph nodes in the area. The main goal is to see if the less extensive surgery leads to similar rates of the cancer not returning within two years, while potentially causing fewer complications like swelling and wound problems.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Cedars-Sinai Medical Centre
NOT_YET_RECRUITING

Los Angeles, California, 90025, United States

Contact
Melanoma Institute Australia
RECRUITING

Wollstonecraft, New South Wales, 2065, Australia

Contact
North Shore Hospital
NOT_YET_RECRUITING

Takapuna, Auklnad, New Zealand

Contact
San Maria della Misericordia Hospital
NOT_YET_RECRUITING

Perugia, Italy

Contact
Sunnybrook Health Sciences Centre
NOT_YET_RECRUITING

Toronto, Ontario, Canada

Contact
The Royal Marsden
NOT_YET_RECRUITING

London, United Kingdom

Contact

Conditions

Explore the condition pages connected to this study.

CUTANEOUS MELANOMA, STAGE III